Clinical Guidelines > Current Guidelines >

BHIVA guidelines for the management of tuberculosis in adults living with HIV 2018 (2021 interim update)

Introduction

The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. Recommendations for the treatment of TB in adults living with HIV are similar to those in HIV-negative adults. Of note, the term ‘HIV’ refers to HIV-1 throughout these guidelines.

The 2021 interim update to the 2018 BHIVA guidelines for the management of tuberculosis in adults living with HIV was published to ensure that guidance reflects new research data, including data from the World Health Organization, on management of drug-resistant TB. All changes are highlighted.


Downloads

British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2018 (2021 interim update)


Additional information

Literature search strategies


Public consultation comments

The comments received during the public consultation can be found below. All comments were reviewed and discussed and the guidelines amended where appropriate.

Download the comments received by the BHIVA Secretariat during the web consultation process


Non-technical summary

View non-technical summary

Please note: The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with your healthcare professionals.


Declaration of interests

Download the declaration of interests from writing group members


Writing group members

  • Margherita Bracchi, Chelsea and Westminster Hospital, NHS Foundation Trust

  • Clare van Halsema, North Manchester General Hospital, Liverpool School of Tropical Medicine

  • Frank Post, King's College Hospital NHS Foundation Trust

  • Funmi Awosusi, Barts Health NHS Trust, HIVPA

  • Alison Barbour, Croydon Health Services NHS Trust

  • Steve Bradley, UK Community Advisory Board

  • Katherine Coyne, Homerton University Hospital

  • Esther Dixon-Williams, UK Community Advisory Board

  • Andrew Freedman, Cardiff University School of Medicine

  • Pauline Jelliman, Royal Liverpool and Broadgreen University Hospital Trust, NHIVNA

  • Saye Khoo, University of Liverpool

  • Clifford Leen, NHS Lothian

  • Marc Lipman, Royal Free London NHS Foundation Trust

  • Sebastian Lucas, Guy's and St Thomas' Hospital NHS Foundation Trust

  • Rob Miller, Mortimer Market Centre

  • Kay Seden, University of Liverpool

  • Anton Pozniak (Chair), Chelsea and Westminster Hospital NHS Foundation Trust


Guidelines updates and date of next review

We aim to revise these guidelines in 2021. In the meantime, the writing group will confer at least annually to consider new information from high-quality studies and will issue revisions or updates should clinically important and relevant data become available.